# Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults

> **NCT07440238** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 200 (estimated)

## Conditions studied

- Septic Arthritis

## Interventions

- **DRUG:** oral prednisone or placebo at a dose of 60 mg per day for 7 days

## Key facts

- **NCT ID:** NCT07440238
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-30
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07440238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07440238, "Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07440238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*